"Alison was the preeminent scholar on adolescent obesity and eating disorders,” said Kerri Boutelle, a pediatrics professor ...

A fat activist explains why she objects to the medicalization of larger bodies and the idea that obesity is a disease.

To address these problems, both Indonesia and Mexico can learn from Japan, the only country to get rich without its ...

Learn the connection between obesity and juvenile type 1 diabetes and how excess weight can complicate the management of this ...

Results showed patients with a BMI of 40 kg/m2 or more who used glucagon-like peptide-1 receptor agonists for at least 90 ...

The director of the Bariatric & Metabolic Institute at Cleveland Clinic Weston Hospital describes how you can keep up with ...

The startup, which has already raised more than half a billion dollars, released Phase 2 results that could position its drug ...

For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious ...

Obesity is a common problem in society at large, but is seen at higher rates among persons living with mental disorders. The ...

How GLP-1 therapies could help build a healthier, more productive workforce—and what that would mean for how we live together ...

Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share ...

GURU Rajiv Kovil, a senior diabetologist and obesity specialist, offers advice on how you can alter your diet and lifestyle ...